1. A novel therapeutic management for diabetes patients with chronic limb-threatening ischemia: comparison of autologous bone marrow mononuclear cells versus allogenic Wharton jelly-derived mesenchymal stem cells
   Martha L. Arango-Rodríguez et al, 2023, Stem Cell Research & Therapy CrossRef
2. Modalities to Deliver Cell Therapy for Treatment of Chronic Limb Threatening Ischemia
   Ocean Setia et al, 2024, Advances in Wound Care CrossRef
3. One-Year Analysis of Autologous Peripheral Blood Mononuclear Cells as Adjuvant Therapy in Treatment of Diabetic Revascularizable Patients Affected by Chronic Limb-Threatening Ischemia: Real-World Data from Italian Registry ROTARI
   Sergio Furgiuele et al, 2024, Journal of Clinical Medicine CrossRef
4. Exploring the Effects of Human Bone Marrow-Derived Mononuclear Cells on Angiogenesis In Vitro
   Judith A. H. M. Peeters et al, 2023, International Journal of Molecular Sciences CrossRef
5. The Immune-Centric Revolution in the Diabetic Foot: Monocytes and Lymphocytes Role in Wound Healing and Tissue Regeneration—A Narrative Review
   Laura Rehak et al, 2022, Journal of Clinical Medicine CrossRef
6. Age-related ultrastructural changes in spheroids of the adipose-derived multipotent mesenchymal stromal cells from ovariectomized mice
   Vitalii Kyryk et al, 2023, Frontiers in Cellular Neuroscience CrossRef
7. Mesenchymal stem cell-based therapy for non-healing wounds due to chronic limb-threatening ischemia: A review of preclinical and clinical studies
   Carlos Theodore Huerta et al, 2023, Frontiers in Cardiovascular Medicine CrossRef
8. Novel therapeutic targets for diabetes-related wounds or ulcers: an update on preclinical and clinical research
   Jonathan Golledge et al, 2021, Expert Opinion on Therapeutic Targets CrossRef
9. Applying adipose tissue-derived stem cell therapies as a novel treatment for atherosclerotic plaque development: Importance of appropriate dosing
   Michael F. Allen et al, 2024, Journal of Molecular and Cellular Cardiology Plus CrossRef
10. Autologous cell therapy for ischemic diabetic foot: a meta-analysis of randomized controlled trials for the development of the Italian guidelines for the treatment of diabetic foot syndrome
    Alessia Scatena et al, 2024, Acta Diabetologica CrossRef
11. Mesenchymal Stem Cells: Generalities and Clinical Significance in Feline and Canine Medicine
    Meriem Baouche et al, 2023, Animals CrossRef
12. Co-Delivery of Bioengineered Exosomes and Oxygen for Treating Critical Limb Ischemia in Diabetic Mice
    Ting Zhong et al, 2023, ACS Nano CrossRef
13. Large extracellular vesicles from induced pluripotent stem cell-marrow stem cells enhance limb angiogenesis via ERK/MAPK
    Ziyu Huang et al, 2024, Nanomedicine CrossRef
14. Novel Use of Intraarticular Granulocyte Colony Stimulating Factor (hG-CSF) Combined with Activated Autologous Peripheral Blood Stem Cells Mobilized with Systemic hG-CSF: Safe and Efficient in Early Osteoarthritis
    Konstantinos I. Papadopoulos et al, 2021, CARTILAGE CrossRef
15. Cell Therapy of Severe Ischemia in People with Diabetic Foot Ulcers—Do We Have Enough Evidence?
    Michal Dubský et al, 2023, Molecular Diagnosis & Therapy CrossRef
16. Autologous Immune Cell-Based Regenerative Therapies to Treat Vasculogenic Erectile Dysfunction: Is the Immuno-Centric Revolution Ready for the Prime Time?
    Michela Bonanni et al, 2022, Biomedicines CrossRef
17. Estrogen‐related receptor alpha is anAMPK‐regulated factor that promotes ischemic muscle revascularization and recovery in diet‐induced obese mice
    Danesh H. Sopariwala et al, 2022, FASEB BioAdvances CrossRef
18. Results of a prospective observational study of autologous peripheral blood mononuclear cell therapy for no-option critical limb-threatening ischemia and severe diabetic foot ulcers
    Andrea Panunzi et al, 2022, Cardiovascular Diabetology CrossRef
19. The Effects of Immunosuppressive Drugs on the Characteristics and Functional Properties of Bone Marrow-Derived Stem Cells Isolated from Patients with Diabetes Mellitus and Peripheral Arterial Disease
    Jitka Husakova et al, 2023, Biomedicines CrossRef
20. Marrow changes and reduced proliferative capacity of mesenchymal stromal cells from patients with “no-option” critical limb ischemia; observations on feasibility of the autologous approach from a clinical trial
    Sara Azhari Mohamed et al, 2022, Cytotherapy CrossRef